Recommendation of the use of myeloblast percentage among non-erythroid cells instead of percentage among total nucleated cells for therapeutic response assessment in acute erythroid leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/16690527

Download in:

View as

General Info

PMID
16690527